TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 6822483

Group type: EXPERIMENTAL
Intervention: Identified patients treated with maprotiline (16 of 25)
Number of subjects: 1086

Group type: EXPERIMENTAL
Intervention: Identified patients electively not treated
Number of subjects: 1086

Group type: COMPARATOR
Intervention: Control group (not identified)
Number of subjects: 1086
Study: 31472076

Group type: EXPERIMENTAL
Intervention: Drought treatment
Number of subjects: 300

Group type: COMPARATOR
Intervention: Non-droughted seedlings
Number of subjects: 300
Study: 29526386

Group type: EXPERIMENTAL
Intervention: Systematic alphanumeric‐coded endoscopy
Number of subjects: 50

Group type: COMPARATOR
Intervention: Conventional endoscopy
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Both techniques
Number of subjects: 50
Study: 27537555

Group type: EXPERIMENTAL
Intervention: Nurse-led tailored intervention
Number of subjects: 304

Group type: COMPARATOR
Intervention: Standard information
Number of subjects: 304
Study: 25434409

Group type: EXPERIMENTAL
Intervention: Exercise intervention
Number of subjects: 168

Group type: EXPERIMENTAL
Intervention: Health check by a nurse
Number of subjects: 168

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 168

Group type: EXPERIMENTAL
Intervention: Overall (all groups)
Number of subjects: 168

Group type: EXPERIMENTAL
Intervention: All interventions
Number of subjects: 168
Study: 22210297

Group type: EXPERIMENTAL
Intervention: Modified anterior compartment reconstruction procedure
Number of subjects: 105

Group type: COMPARATOR
Intervention: Prolift-a procedure
Number of subjects: 105
Study: 20551820

Group type: EXPERIMENTAL
Intervention: Lichtenstein hernia repair (n=16)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Totally extraperitoneal‐preperitoneal hernia repair (n=16)
Number of subjects: 32
Study: 18544179

Group type: EXPERIMENTAL
Intervention: Fentanyl
Number of subjects: 216

Group type: EXPERIMENTAL
Intervention: Fentanyl and Dexamethasone
Number of subjects: 216
Study: 15516488

Group type: EXPERIMENTAL
Intervention: Low tidal volume ventilation (LTVV)
Number of subjects: 0

Group type: COMPARATOR
Intervention: sTNFRI and II levels
Number of subjects: 0
Study: 11196519

Group type: EXPERIMENTAL
Intervention: Home based physical therapy (PT) intervention (education, exercise, and pain relief modalities) delivered by physiotherapists with advanced rheumatology training for 6 weeks.
Number of subjects: 127

Group type: COMPARATOR
Intervention: Wait list control group receiving the PT intervention between Weeks 6 to 12.
Number of subjects: 127
Study: 9601678

Group type: EXPERIMENTAL
Intervention: Dichotic tones of different frequencies
Number of subjects: 0
Study: 7989934

Group type: EXPERIMENTAL
Intervention: Systemic chemotherapy regimens and CNS prophylaxis regimens (intrathecal methotrexate alone or intrathecal methotrexate plus 18 Gy cranial irradiation)
Number of subjects: 1544

Group type: COMPARATOR
Intervention: CNS prophylaxis regimens (intrathecal methotrexate alone or intrathecal methotrexate plus 18 Gy cranial irradiation)
Number of subjects: 1544
Study: 2589907

Group type: EXPERIMENTAL
Intervention: Double wash swim-up technique
Number of subjects: 73
Study: 178227

Group type: EXPERIMENTAL
Intervention: Angiography
Number of subjects: 100

Group type: COMPARATOR
Intervention: Preexisting renal disease or cardiovascular disease
Number of subjects: 100

Group type: COMPARATOR
Intervention: Contrast volume
Number of subjects: 100
Study: 30964697

Group type: EXPERIMENTAL
Intervention: Dynamic Anterior Shoulder Stabilization (DAS)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Isolated Bankart repair
Number of subjects: 24
Study: 29193019

Group type: EXPERIMENTAL
Intervention: Lenalidomide (25 mg/day orally on days 1-21; 28-day cycles)
Number of subjects: 254

Group type: COMPARATOR
Intervention: Investigator's choice (IC) therapy (rituximab, gemcitabine, fludarabine, chlorambucil or cytarabine)
Number of subjects: 254

Group type: EXPERIMENTAL
Intervention: Lenalidomide
Number of subjects: 254
Study: 26856623

Group type: EXPERIMENTAL
Intervention: Rice with soya beancurd (RWT)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Rice with fish (RWF)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Rice with egg white (RWE)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Rice with chicken (RWC)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Rice alone (control)
Number of subjects: 15
Study: 24740312

Group type: EXPERIMENTAL
Intervention: Sugammadex 1 mg·kg(‐1)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 20
Study: 22664647

Group type: EXPERIMENTAL
Intervention: Weight management intervention via conference call
Number of subjects: 395

Group type: COMPARATOR
Intervention: Traditional face-to-face (FTF) approach
Number of subjects: 395
Study: 19707086

Group type: EXPERIMENTAL
Intervention: Automated telephone intervention (daily messages regarding diabetes)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 120
Study: 17526954

Group type: EXPERIMENTAL
Intervention: Vitamin A supplementation
Number of subjects: 528

Group type: COMPARATOR
Intervention: Control
Number of subjects: 528
Study: 15300580

Group type: EXPERIMENTAL
Intervention: Nadolol (mean dose 62 +/- 25 mg/day, adjusted to decrease resting heart rate by 25%)
Number of subjects: 161

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 161

Group type: EXPERIMENTAL
Intervention: Nadolol
Number of subjects: 161
Study: 11123382

Group type: EXPERIMENTAL
Intervention: MDMA (100 mg)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Ethanol (0.8 g/kg)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Combination of MDMA and ethanol
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study: 9642331

Group type: EXPERIMENTAL
Intervention: Desflurane
Number of subjects: 42

Group type: COMPARATOR
Intervention: Sevoflurane
Number of subjects: 42

Group type: COMPARATOR
Intervention: Enflurane
Number of subjects: 42
Study: 8095150

Group type: EXPERIMENTAL
Intervention: epanolol (200 mg once daily)
Number of subjects: 16

Group type: COMPARATOR
Intervention: diltiazem (60 mg three times daily)
Number of subjects: 16

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 16
Study: 3688375

Group type: EXPERIMENTAL
Intervention: Beclomethasone dipropionate (BPD) at concentrations of 0.1 mg/ml, 0.05 mg/ml, 0.005 mg/ml, and 0.0005 mg/ml
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Flunisolide at concentrations of 0.25 mg/ml, 0.05 mg/ml, 0.025 mg/ml, and 0.00025 mg/ml
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Propylene glycol at concentrations of 20 mg/ml and 200 mg/ml
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 29357963

Group type: EXPERIMENTAL
Intervention: Infants of highly educated mothers
Number of subjects: 715

Group type: EXPERIMENTAL
Intervention: Infants of multiparous mothers
Number of subjects: 715

Group type: EXPERIMENTAL
Intervention: Infants of mothers with overweight/obesity
Number of subjects: 715
Study: 27475099

Group type: EXPERIMENTAL
Intervention: 2% mepivacaine with 1:100,000 epinephrine
Number of subjects: 42

Group type: COMPARATOR
Intervention: 2% lidocaine with 1:100,000 epinephrine
Number of subjects: 42
Study: 24192662

Group type: EXPERIMENTAL
Intervention: Labour induction
Number of subjects: 650

Group type: COMPARATOR
Intervention: Expectant monitoring
Number of subjects: 650
Study: 23887076

Group type: EXPERIMENTAL
Intervention: multimodal analgesic regimen (celecoxib, pregabalin, extended release oxycodone)
Number of subjects: 22

Group type: COMPARATOR
Intervention: intravenous morphine
Number of subjects: 22
Study: 20033052

Group type: EXPERIMENTAL
Intervention: L84‐11 study
Number of subjects: 1846

Group type: EXPERIMENTAL
Intervention: L89‐12 study
Number of subjects: 1846

Group type: EXPERIMENTAL
Intervention: L92‐13 study
Number of subjects: 1846

Group type: EXPERIMENTAL
Intervention: L95‐14 study
Number of subjects: 1846

Group type: COMPARATOR
Intervention: Intermediate- or high-dose methotrexate therapy
Number of subjects: 1846

Group type: COMPARATOR
Intervention: Dexamethasone 8 mg/m(2)
Number of subjects: 1846

Group type: EXPERIMENTAL
Intervention: Prophylactic cranial irradiation
Number of subjects: 1846

Group type: EXPERIMENTAL
Intervention: Secondary brain tumors
Number of subjects: 1846
Study: 18685526

Group type: EXPERIMENTAL
Intervention: Creatine + Protein (CP)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Creatine (C)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 35
Study: 16736065

Group type: EXPERIMENTAL
Intervention: New infant formula containing partially hydrolysed whey proteins and prebiotic oligosaccharides
Number of subjects: 267

Group type: COMPARATOR
Intervention: Standard formula and simethicone (6 mg/kg twice a day)
Number of subjects: 267
Study: 12745852

Group type: EXPERIMENTAL
Intervention: Ketoconazole cream
Number of subjects: 73

Group type: COMPARATOR
Intervention: Placebo cream
Number of subjects: 73
Study: 10965161

Group type: EXPERIMENTAL
Intervention: tolcapone (200 mg t.i.d.)
Number of subjects: 22

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 22
Study: 8988072

Group type: EXPERIMENTAL
Intervention: Atorvastatin 0.5 to 80 mg/day
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 7698138

Group type: EXPERIMENTAL
Intervention: Felodipine
Number of subjects: 42

Group type: COMPARATOR
Intervention: Diuretic (hydrochlorothiazide + triamterene)
Number of subjects: 42
Study: 2956516

Group type: EXPERIMENTAL
Intervention: Immediate angioplasty (n = 99)
Number of subjects: 386

Group type: COMPARATOR
Intervention: Elective angioplasty (n = 98)
Number of subjects: 386
Study: 29482588

Group type: EXPERIMENTAL
Intervention: Rifaximin 550 mg twice daily for 18 months
Number of subjects: 136

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 136
Study: 29354993

Group type: EXPERIMENTAL
Intervention: Joss stick moxibustion combined with pricking and cupping
Number of subjects: 70

Group type: COMPARATOR
Intervention: Conventional western medication (oral acyclovir, vitamin B1, mecobalamin tablets, and interferon injection)
Number of subjects: 70
Study: 24406537

Group type: EXPERIMENTAL
Intervention: Cardiac pacing therapy
Number of subjects: 162

Group type: COMPARATOR
Intervention: No cardiac pacing therapy (Control)
Number of subjects: 162
Study: 22488880

Group type: EXPERIMENTAL
Intervention: Allograft combined with PRP (n = 85)
Number of subjects: 254

Group type: EXPERIMENTAL
Intervention: Autograft alone (n = 101)
Number of subjects: 254

Group type: COMPARATOR
Intervention: Allograft alone (n = 90)
Number of subjects: 254
Study: 20562165

Group type: EXPERIMENTAL
Intervention: Surface EMG biofeedback training (4 weeks)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Interdisciplinary rehabilitation (control group)
Number of subjects: 65
Study: 17959524

Group type: EXPERIMENTAL
Intervention: Endogenetic field hyperthermia (EFH) combined with FOLFOX regimen
Number of subjects: 147

Group type: COMPARATOR
Intervention: FOLFOX regimen alone (Control group)
Number of subjects: 147
Study: 16329383

Group type: EXPERIMENTAL
Intervention: Alcon CustomCornea laser system
Number of subjects: 30

Group type: COMPARATOR
Intervention: WaveLight Allegretto Wave laser system
Number of subjects: 30
Study: 12477069

Group type: EXPERIMENTAL
Intervention: Exact method for sample size and power determination
Number of subjects: 0

Group type: COMPARATOR
Intervention: Asymptotic methods
Number of subjects: 0
Study: 9507787

Group type: EXPERIMENTAL
Intervention: Enalapril 5 mg plus diltiazem ER 120 mg or 180 mg
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Enalapril/diltiazem ER alone
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Enalapril/diltiazem ER
Number of subjects: 112
Study: 9050491

Group type: EXPERIMENTAL
Intervention: Laparoscopic salpingo-oophorectomy
Number of subjects: 20

Group type: COMPARATOR
Intervention: Laparotomy
Number of subjects: 20
Study: 3275523

Group type: EXPERIMENTAL
Intervention: Sublingual buprenorphine (2 mg for 3 weeks, followed by dose reductions and placebo)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Oral methadone (30 mg for 3 weeks, followed by dose reductions and placebo)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Methadone during hydromorphone challenge
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Buprenorphine during hydromorphone challenge
Number of subjects: 45
Study: 30422257

Group type: EXPERIMENTAL
Intervention: Antipsychotic medications (5 atypical and 2 typical) for 6 weeks
Number of subjects: 3023

Group type: EXPERIMENTAL
Intervention: Whole-exome sequencing (WES)
Number of subjects: 3023

Group type: EXPERIMENTAL
Intervention: Targeted sequencing
Number of subjects: 3023
Study: 28600189

Group type: EXPERIMENTAL
Intervention: 80 mg simvastatin
Number of subjects: 140

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 140
Study: 26187714

Group type: EXPERIMENTAL
Intervention: Audiovisual biofeedback system
Number of subjects: 75

Group type: COMPARATOR
Intervention: Control group (no audiovisual biofeedback)
Number of subjects: 75
Study: 23142150

Group type: EXPERIMENTAL
Intervention: Escitalopram treatment
Number of subjects: 46
Study: 21393464

Group type: EXPERIMENTAL
Intervention: Acetazolamide (250 mg)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Dexamethasone (4 mg)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 18513524

Group type: EXPERIMENTAL
Intervention: Distal protection devices during rescue PCI
Number of subjects: 93

Group type: COMPARATOR
Intervention: Primary PCI
Number of subjects: 93
Study: 16817525

Group type: EXPERIMENTAL
Intervention: Semantic feature ratings by participants
Number of subjects: 0
Study: 14557155

Group type: COMPARATOR
Intervention: Epinephrine vs Placebo
Number of subjects: 14

Group type: COMPARATOR
Intervention: Epinephrine vs Albuterol sulfate (salbutamol)
Number of subjects: 14
Study: 11065068

Group type: EXPERIMENTAL
Intervention: Breastfeeding
Number of subjects: 264

Group type: EXPERIMENTAL
Intervention: Breastfeeding duration
Number of subjects: 264

Group type: EXPERIMENTAL
Intervention: Socioeconomic status
Number of subjects: 264

Group type: EXPERIMENTAL
Intervention: Complementary feeding practices
Number of subjects: 264

Group type: EXPERIMENTAL
Intervention: Diet quality
Number of subjects: 264
Study: 9135750

Group type: EXPERIMENTAL
Intervention: Laser guide for aiming the image intensifier
Number of subjects: 52
Study: 1467901

Group type: EXPERIMENTAL
Intervention: Open drainage method, N=22
Number of subjects: 43

Group type: COMPARATOR
Intervention: Capsulorrhaphy without drainage, N=21
Number of subjects: 43
Study: 6363660

Group type: EXPERIMENTAL
Intervention: Amoxicillin (40 mg/kg/day in three doses for 10 days)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Cefaclor (40 mg/kg/day in three doses for 10 days)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Both treatments (Amoxicillin and Cefaclor)
Number of subjects: 50
Study: 31449469

Group type: EXPERIMENTAL
Intervention: Proton beam radiation therapy
Number of subjects: 70
Study: 30409289

Group type: EXPERIMENTAL
Intervention: Hospital-based exercise program (40min, three times a week for four weeks)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Home-based exercise program
Number of subjects: 40
Study: 26613286

Group type: EXPERIMENTAL
Intervention: Panitumumab plus FOLFOX4
Number of subjects: 0

Group type: COMPARATOR
Intervention: FOLFOX4 alone
Number of subjects: 0
Study: 23293845

Group type: EXPERIMENTAL
Intervention: TRAIN (strength‐trained one shoulder)
Number of subjects: 23

Group type: COMPARATOR
Intervention: CONTROL (no intervention)
Number of subjects: 23
Study: 22391537

Group type: EXPERIMENTAL
Intervention: CMX001 (0.25 to 2.0 mg/kg single doses; 0.1 to 1.0 mg/kg multiple doses, 3 doses every 6 days)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 20528000

Group type: EXPERIMENTAL
Intervention: Fixed maintenance-dose budesonide/formoterol
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Adjustable maintenance-dose budesonide/formoterol
Number of subjects: 100

Group type: COMPARATOR
Intervention: Fixed maintenance-dose salmeterol/fluticasone propionate
Number of subjects: 100
Study: 17585004

Group type: EXPERIMENTAL
Intervention: 5-day antibiotic therapy duration
Number of subjects: 88

Group type: COMPARATOR
Intervention: 10-day antibiotic therapy duration
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Increased days of diarrhea as a side effect
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Dosing frequency (once daily vs. twice daily)
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Failure rates
Number of subjects: 88
Study: 16216004

Group type: EXPERIMENTAL
Intervention: Low molecular weight heparin (LMWH)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard cancer care
Number of subjects: 0
Study: 12140400

Group type: EXPERIMENTAL
Intervention: Platelet aggregation inhibitors
Number of subjects: 32918

Group type: COMPARATOR
Intervention: Antihypertensive agents
Number of subjects: 32918

Group type: COMPARATOR
Intervention: Cholesterol‐lowering medication
Number of subjects: 32918

Group type: COMPARATOR
Intervention: Antidiabetic agents
Number of subjects: 32918
Study: 10400003

Group type: EXPERIMENTAL
Intervention: Quinapril (40 mg daily for two weeks)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Losartan (50 mg daily for two weeks)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 7675968

Group type: EXPERIMENTAL
Intervention: Scopolamine (0.5 mg SC)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lorazepam (2.5 mg PO)
Number of subjects: 0
Study: 2188379

Group type: EXPERIMENTAL
Intervention: Bezafibrate 200 mg three times daily
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Simvastatin 10 mg daily
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Simvastatin 20 mg daily
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Simvastatin 40 mg daily
Number of subjects: 0

Group type: COMPARATOR
Intervention: Comparison of Simvastatin vs Bezafibrate
Number of subjects: 0
Study: 6973987

Group type: EXPERIMENTAL
Intervention: Fluproquazone 200 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Paracetamol 500 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Propoxyphene 65 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Fluproquazone 100 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Fluproquazone
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 30903423

Group type: EXPERIMENTAL
Intervention: Group dynamic assessment
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Vocabulary enhancement exercises
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Combination of group dynamic assessment and vocabulary exercises
Number of subjects: 45
Study: 27484775

Group type: EXPERIMENTAL
Intervention: 12-month no-cost YMCA membership
Number of subjects: 91
Study: 26104940

Group type: EXPERIMENTAL
Intervention: RTOG vascular expansion technique
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Modified RTOG vascular expansion technique
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: PIVOTAL trial vascular expansion technique
Number of subjects: 7

Group type: COMPARATOR
Intervention: RMH technique
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Modified RTOG with 3-mm BEM
Number of subjects: 7
Study: 23597289

Group type: EXPERIMENTAL
Intervention: SGI group (slow growth increase)
Number of subjects: 24
Study: 21954478

Group type: EXPERIMENTAL
Intervention: Saw palmetto extract (320 mg/d)
Number of subjects: 369

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 369

Group type: COMPARATOR
Intervention: Saw palmetto extract vs. placebo
Number of subjects: 369
Study: 19703372

Group type: EXPERIMENTAL
Intervention: Intranasal sumatriptan 10 mg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Intranasal sumatriptan 20 mg
Number of subjects: 12

Group type: COMPARATOR
Intervention: Subcutaneous sumatriptan 6 mg
Number of subjects: 12
Study: 16918641

Group type: EXPERIMENTAL
Intervention: Topical vitamin E
Number of subjects: 3

Group type: COMPARATOR
Intervention: Placebo oil
Number of subjects: 3
Study: 15530916

Group type: EXPERIMENTAL
Intervention: Dealcoholised red wine (DRW)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Red wine (RW)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Water
Number of subjects: 17
Study: 10927040

Group type: COMPARATOR
Intervention: Multicolor fluorescence in situ hybridization (FISH) of peripheral blood lymphocytes and spermatozoa using a probe cocktail for chromosomes X, Y, and 21.
Number of subjects: 20
Study: 9314462

Group type: EXPERIMENTAL
Intervention: Monthly intramuscular injections of benzathine penicillin G
Number of subjects: 115

Group type: COMPARATOR
Intervention: No prophylaxis (control group)
Number of subjects: 115
Study: 8362174

Group type: EXPERIMENTAL
Intervention: Methacholine
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study: 3741286

Group type: EXPERIMENTAL
Intervention: Naloxone
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 30557205

Group type: EXPERIMENTAL
Intervention: Virtual dementia experience (n = 56)
Number of subjects: 112

Group type: COMPARATOR
Intervention: Standard teaching approaches
Number of subjects: 112
Study: 29482218

Group type: EXPERIMENTAL
Intervention: Collaborative Care to Alleviate Symptoms and Adjust to Illness (CASA) intervention
Number of subjects: 314

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 314

Group type: EXPERIMENTAL
Intervention: CASA intervention
Number of subjects: 314
Study: 27228979

Group type: EXPERIMENTAL
Intervention: Task sharing counselling intervention
Number of subjects: 26
Study: 24177229

Group type: EXPERIMENTAL
Intervention: REORDER intervention
Number of subjects: 226

Group type: COMPARATOR
Intervention: Enhanced treatment as usual
Number of subjects: 226
Study: 22198517

Group type: EXPERIMENTAL
Intervention: PCV13
Number of subjects: 168

Group type: COMPARATOR
Intervention: PCV7
Number of subjects: 168
Study: 20957693

Group type: EXPERIMENTAL
Intervention: Escitalopram with Interpersonal Psychotherapy (IPT)
Number of subjects: 124

Group type: COMPARATOR
Intervention: Escitalopram with Depression Care Management (DCM)
Number of subjects: 124
Study: 17430381

Group type: EXPERIMENTAL
Intervention: BOTOX plus EPI 1:100,000
Number of subjects: 14

Group type: COMPARATOR
Intervention: BOTOX
Number of subjects: 14
Study: 16281190

Group type: EXPERIMENTAL
Intervention: Single-session modified behavioral treatment (SSBT)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Waiting list control condition (WL)
Number of subjects: 59